References
- Feldmann M, Brennan, FM, Maini RN: Rheumatoid arthritis. Cell 85;307-310, 1996 https://doi.org/10.1016/S0092-8674(00)81109-5
- Firestein GS: Invasive fibroblast-like synoviocytes in rheumatoid arthritis. passive responders or transformed aggressors? Arthritis Rheum 39;1781-1790, 1996 https://doi.org/10.1002/art.1780391103
- Bucala R, Ritchlin C, Winchester R, Cerami A: Constitutive production of inflammatory and mitogenic cytokines by rheumatoid synovial fibroblasts. J Exp Med 173;569-574, 1991 https://doi.org/10.1084/jem.173.3.569
- Roivainen A, Jalava J, Pirila L, Yli-Jama T, Tiusanen H, Toivanen P: H-ras oncogene point mutations in arthritic synovium. Arthritis Rheum 40;1636-1643, 1997 https://doi.org/10.1002/art.1780400913
- Firestein GS, Echeverri F, Yeo M, Zvaifler NJ, Green DR: Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium. Proc Natl Acad Sci USA 94;10895-10900, 1997
- Baksh S, Burakoff SJ: The role of calcineurin in lymphocyte activation. Semin Immunol 12;405-415, 2000 https://doi.org/10.1006/smim.2000.0221
- Liossis SN, Kovacs B, Dennis G, Kammer GM, Tsokos GC: B cells from patients with systemic lupus erythematosus display abnormal antigen receptor- mediated early signal transduction events. J Clin Invest 98;2549-2557, 1996 https://doi.org/10.1172/JCI119073
- Liossis SN, Ding XZ, Dennis GJ, Tsokos GC: Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain. J Clin Invest 101;1448-1457, 1998 https://doi.org/10.1172/JCI1457
- Crabtree GR, Olson EN: NFAT signaling: choreographing the social lives of cells. Cell 109;S67-79, 2002 https://doi.org/10.1016/S0092-8674(02)00699-2
- Tugwell P, Pincus T, Yocum D, Stein M, Gluck O, Kraag G, McKendry R, Tesser J, Baker P, Wells G: Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. The Methotrexate-Cyclosporine Combination Study Group. N Engl J Med 333;137-141, 1995 https://doi.org/10.1056/NEJM199507203330301
- Firestein GS: Evolving concepts of rheumatoid arthritis. Nature 423;356-361, 2003 https://doi.org/10.1038/nature01661
- Franks JJ, Wamil AW, Janicki PK, Horn JL, Franks WT, Janson VE, Vanaman TC, Brandt PC: Anesthetic-induced alteration of Ca2+ homeostasis in neural cells: a temperaturesensitive process that is enhanced by blockade of plasma membrane Ca2+-ATPase isoforms. Anesthesiology 89;149- 164, 1998 https://doi.org/10.1097/00000542-199807000-00022
- Cho CS, Cho ML, Min SY, Kim WU, Min DJ, Lee SS, Park SH, Choe J, Kim HY: CD40 engagement on synovial fibroblast up-regulates production of vascular endothelial growth factor. J Immunol 164;5055-5061, 2000 https://doi.org/10.4049/jimmunol.164.10.5055
- Miyazawa K, Mori A, Okudaira H: Establishment and characterization of a novel human rheumatoid fibroblast-like synoviocyte line, MH7A, immortalized with SV40 T antigen. J Biochem 124;1153-1162, 1998 https://doi.org/10.1093/oxfordjournals.jbchem.a022233
- Kim WU, Lee WK, Ryoo JW, Kim SH, Kim J, Youn J, Min SY, Bae EY, Hwang SY, Park SH, Cho CS, Park JS, Kim HY: Suppression of collagen-induced arthritis by single administration of poly (lactic-co-glycolic acid) nanoparticles entrapping type II collagen: a novel treatment strategy for induction of oral tolerance. Arthritis Rheum 46;1109-1120, 2002 https://doi.org/10.1002/art.10198
- Klee CB, Crouch TH, Krinks MH: Calcineurin: a calciumand calmodulin-binding protein of the nervous system. Proc Natl Acad Sci USA 76;6270-6273, 1979
- Guerini D, Klee CB: Cloning of human calcineurin A: evidence for two isozymes and identificationof a polyproline structural domain. Proc Natl Acad Sci USA 86;9183-9187, 1989
- Jiang H, Xiong F, Kong S, Ogawa T, Kobayashi M, Liu JO: Distinct tissue and cellular distribution of two major isoforms of calcineurin. Mol Immunol 34;663-669, 1997 https://doi.org/10.1016/S0161-5890(97)00054-0
- Chabaud M, Fossiez F, Taupin JL, Miossec P: Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines. J Immunol 161;409-414, 1998
- Sun L, Youn HD, Loh C, Stolow M, He W, Liu JO: Cabin 1, a negative regulator for calcineurin signaling in T lymphocytes. Immunity 6;703-711, 1998
- Yamamura Y, Gupta R, Morita Y, He X, Pai R, Endres J, Freiberg A, Chung K, Fox DA: Effector function of resting T cells: activation of synovial fibroblasts. J Immunol 166; 2270-2275, 2001 https://doi.org/10.4049/jimmunol.166.4.2270
- Lai MM, Burnett PE, Wolosker H, Blackshaw S, Snyder SH: Cain, a novel physiologic protein inhibitor of calcineurin. J Biol Chem 273;18325-18331, 1998 https://doi.org/10.1074/jbc.273.29.18325
- Cockfield SM, Ramassar V, Halloran PF: Regulation of IFN-gamma and tumor necrosis factor-alpha expression in vivo. Effects of cycloheximide and cyclosporine in normal and lipopolysaccharide-treated mice. J Immunol 150;342-352, 1993
- Tsai EY, Yie J, Thanos D, Goldfeld AE: Cell-type-specific regulation of the human tumor necrosis factor alpha gene in B cells and T cells by NFATp and ATF-2/JUN. Mol Cell Biol 16;5232-5244, 1996 https://doi.org/10.1128/MCB.16.10.5232
- Durez P, Abramowicz D, Gerard C, Van Mechelen M, Amraoui Z, Dubois C, Leo O, Velu T, Goldman M: In vivo induction of interleukin 10 by anti-CD3 monoclonal antibody or bacterial lipopolysaccharide: differential modulation by cyclosporin A. J Exp Med 177;551-555, 1993 https://doi.org/10.1084/jem.177.2.551
- Dumont FJ, Staruch, MJ, Fischer P, DaSilva C, Camacho R: Inhibition of T cell activation by pharmacologic disruption of the MEK1/ERK MAP kinase or calcineurin signaling pathways results in differential modulation of cytokine production. J Immunol 160;2579-2589, 1998
- Li B, Sehajpal PK, Khanna A, Vlassara H, Cerami A, Stenzel KH, Suthanthiran M: Differential regulation of transforming growth factor-beta and interleukin 2 genes in human T cells: demonstration by usage of novel competitor DNA constructs in the quantitative polymerase chain reaction. J Exp Med 174;1259-1262, 1991 https://doi.org/10.1084/jem.174.5.1259
- Van der Pouw Kraan TC, Boeije LC, Troon JT, Rutschmann SK, Wijdenes J, Aarden LA: Human IL-13 production is negatively influenced by CD3 engagement. Enhancement of IL-13 production by cyclosporin A. J Immunol 156;1818-1823, 1996
- Schreiber SL, Crabtree GR: The mechanism of action of cyclosporin A and FK506. Immunol Today 13;136-142, 1992 https://doi.org/10.1016/0167-5699(92)90111-J
- Hong F, Lee J, Song JW, Lee SJ, Ahn H, Cho JJ, Ha J, Kim SS: Cyclosporin A blocks muscle differentiation by inducing oxidative stress and inhibiting the peptidyl-prolyl-cis-trans isomerase activity of cyclophilin A: cyclophilin A protects myoblasts from cyclosporin A-induced cytotoxicity. FASEB J 16;1633-1635, 2002 https://doi.org/10.1096/fj.02-0060fje
- Hong F, Lee J, Piao YJ, Jae YK, Kim YJ, Oh C, Seo JS, Yun YS, Yang CW, Ha J, Kim SS: Transgenic mice overexpressing cyclophilin A are resistant to cyclosporin A-induced nephrotoxicity via peptidyl-prolyl cis-trans isomerase activity. Biochem Biophys Res Commun 316;1073-1080, 2004 https://doi.org/10.1016/j.bbrc.2004.02.160
- Lai MM, Luo HR, Burnett PE, Hong JJ, Snyder SH: The calcineurin-binding protein cain is a negative regulator of synaptic vesicle endocytosis. J Biol Chem 275;34017-34020, 2000 https://doi.org/10.1074/jbc.C000429200
- Taigen T, De Windt LJ, Lim HW, Molkentin JD: Targeted inhibition of calcineurin prevents agonist- induced cardiomyocyte hypertrophy. Proc Natl Acad Sci USA 97;1196-1201, 2000